Long -term costs related to medical use of cancer patients in Scotland

Laudicella, M., Walsh, B., Burns, E., Smith, PC: British cancer patient treatment cost: Evidence of demographic patient level data. Br. J. Cancer 1141286–1292 (2016)

Kutikova, L., Bowman, L., Chang, S., Long, SR, Obasaju, C., Crown, WH: Economic burden of lung cancer and the cost -related costs of the United States. lung. cancer. (Amsterdam, the Netherlands). 50143–154 (2005)

PISU, M., Henrikson, NB, BANEGAS, MP, YABROFF, KR: Cancer costs with therapeutic continuum: Cancer expenses: You can expect based on recent literature. cancer 1244181–4191 (2018)

BANEGAS, MP, YABROFF, KR, O’Keeffe-Rosetti, MC, Ritzwoller, DP, Fishman, Pa, Salloum, RG, etc. J. NATL. St. Khan. Netw. 16402–410 (2018)

Blakely, T., Atkinson, J., KvizhinAdze, G., Wilson, N., Davies, A., Clarke, P. Med. care. 53302–309 (2015)

Yabroff, Kr, Lamont, EB, Mariotto JNCI: J. National. cancer. INST. 100630–41 (2008)

Lang, K., Huang, H., Sasane, M., PALY, VF, Hao, Y., Menzin, J.: Survival and cost of IV step ER + breast cancer patients without HER2 target therapy. BMC health. Serving. seacoast 14298 (2014)

article
PubMed
PUBMED CENTRAL

HANCHATE, AD, Cloud-Gorr, Km, Ash, AS, Thin, SS, Silliman, RA: The end pattern of survival, companionship, medical use and treatment quality of elderly women after breast cancer diagnosis. J. Gen. intern. Med. 251045–1050 (2010)

article
PubMed
PUBMED CENTRAL

Khanna, R., Madhavan, SS, Bhanegaonkar, A., Remick, SC: Use and breast cancer costs of breast cancer in the main Medicaid fee program. J. Woman. health. 20739–747 (2011)

LANG, K., Lines, LM, Lee, DW, KORN, JR, Earle, CC, Menzin, J.: Medical use trend of elderly Americans with colon cancer: After -fragrant database analysis. BMC health. Serving. seacoast 9227 (2009)

article
PubMed
PUBMED CENTRAL

Song, X., Zhao, Z., Barber, B., Gregory, C., CAO, Z., Gao, S. J. Med. Econ. 141–9 (2011)

article
Cass
PubMed

Jayadevappa, R., Chhatre, S., Weiner, M., Bloom, BS, MALKOWICZ, SB: Prostate cancer patients. Urol. Oncol. 23155–162 (2005)

Chang, S., Long, SR, Kutikova, L., Bowman, L., Finley, D., Crown, WH etc at: Cancer expenses: Climb data analysis for cancer patients diagnosed with cancer from 1999 to 2000. J. Clin. Oncol. : turn off. J. am. Social Clean. Oncol. 223524–3530 (2004)

Cherla, A., Renwick, M., JHA, A., Mossialos, E.: Cost Efficiency of Cancer Drugs: Comparative Analysis of the United States and the United Kingdom. EclinicalMedicine. 29–30, 100625 (2020). https://www.thelancet.com/journals/eclinm/article/piis2589-5370 (20)30369-2/fullText

Vokinger, KN, HWANG, TJ, Grischott, T., Reichert, S., Tibau, A., Rosemann, T. etc: Price and clinical advantages of cancer drugs in the United States and Europe: cost -profit analysis. lance. Oncol. 21664–670 (2020)

article
Cass
PubMed

Murray, CJL, Richards, MA, Newton, JN, Fenton, Ka, Anderson, HR, ATKINSON, C., et al. : UK Health Performance: Results of global burden of disease research results 2010. Lancet (London, UK). 381997–1020 (2013)

Hilhorst, S., LOCKEY, A.: Cancer Cost: ‘Rupture Effect’ Analysis on Cancer’s Wider Influence (Internet). 2020. Available: www.demos.co.uk

Hall, b. J. Cancer. 112948–956 (2015)

article
Cass
PubMed
PUBMED CENTRAL

Langton, JM, Blanc, B., Drew, Ak, Ak, HaaS, M., Ingham, JM, Pearson, S.-A. : Utilization and cost of termination and cost of cancer treatment of cancer treatment using health care data: systematic review. mitigation. Med. 281167–1196 (2014)

Bosanquet, N., Sikora, K.: Economics of British cancer treatment. lance. Oncol. 5568–574 (2004)

Rim, sh, guy, gp, yabroff, kr, mcgraw, ka, ekwueme, du: Effect of chronic diseases on the economic burden of cancer survival: systematic review. expert. PRMACOECON. Results res. 16579–589 (2016)

Marti, J., Hall, PS, Hamilton, P., Hulme, CT, Jones, H., Velikova, G. etc: Economic burden of cancer in the UK: A study of survivors who are treated by treatment intention. Mental engineering 2577–83 (2015)

Popham, F.: Is there a “Scotland effect” for self -reporting on health? Individual level analysis of the 2001 British Census. BMC release. health. 61–11 (2006)

article

Google Academic Search

Minton, J., Shaw, R., Green, MA, Vanderbloemen, L., Popham, F., McCartney, G. J. Epidemiol. Community. health. 71461–467 (2017)

McCartney, G., Collins, C., Walsh, D., Batty, GD: Reasons why Scots dies more younger: Evidence synthesis. public health 126459–470 (2012)

article
Cass
PubMed

Economic Cooperation and Development Organization. OECD review of health care quality: UK 2016 (Internet). OECD; From February 2016: available: https://www.oecd.org/en/publications/oecd-lviews- of-health-care-care-carre-united

Gray, L., LEYLAND, AH: Multi -stage analysis of Scotland’s diet and socioeconomic status: ‘Glasso Effect’ survey. Public. health. antelope 121351–1358 (2009)

Shelton, New Jersey: Local risk factors for health inequality in Scotland and the United Kingdom and “Scotland Effect”. Social Sci -fi science. Med. 69761–767 (2009)

McCartney, G., Russ, TC, Walsh, D., Lewsey, J., Smith, M., Smith, GD, etc. J. Epidemiol. Community. health. 6920–27 (2015)

ISD Scotland. National Data Catalog | National Data Set (Internet). 2021 (quoted on November 7, 2021). Can be used: https://www.ndc.scot.nhs.uk/national-datasets/data.asp?subid=23

ISD Scotland. Cancer of Scotland. 2017. Access: https://www.isdscotland.org/Health-topics/cancer/publications

ISD Scotland. Scotland Am Registry (Internet). 2020. Available: https://www.isdscotland.org/Health-topics/cancer/Scottish-cancer-egistry.asp

ISD Scotland. SMR01 Data Scotland 2014–2015. 2014.

Thorn, JC, Turner, EL, HOUNSOME, WALSOME, WALSH, E., DOWN, L., VERNE, J. etc: Comparison of Cost Calculations for Use and Economic Economic Evaluation of Hospital Episodes Statistics: Lifetime End Case in Cluster Random Test of PSA on Prostate Cancer (CAP). BMJ open 6E011063 (2016)

GEUE, C., Lewsey, J., Lorgelly, P., Govan, L., Hart, C., Briggs, a. : Discarded for choice: implications for using alternative methods that cost hospital episode statistics. health. Econ. 211201–1216 (2011)

Wijeysundera, HC, WANG, X., Tomlinson, G., KO, DT, KRAHN, MD: A technology that estimates health care costs with censorship data: Overview for Health Service Research Institute. Clinico. Econ. result. seacoast 4145–155 (2012)

Mihaylova, B., Briggs, A., O’hagan, A., Thompson, SG: Review of statistical methods for medical resources and cost analysis. health. Econ. 20897–916 (2010)

Short, PF, Moran, Jr, Punekar, R.: Medical expenses of 65 -year -old adult cancer survivors in the United States. cancer. 117(12), 2791–2800 (2011). https://doi.org/10.1002/CNCR.25835

Geraci, JM, ESCALANTE, CP, FREEMAN, JL, Goodwin, JS: Combined Disease and Cancer: Needs of more relevant conceptual models in health service studies. J. Clin. Oncol. 237399–7404 (2005)

Steel, D., Cylus, J.: UK (Scotland): Health system review. Health system in conversion. 14(9), 1–150 (2012). https://eprints.lse.ac.uk/49652/

Khushalani, Js, Qin, J., Cyrus, J., Buchanan Lunsford, N., Rim, Sh, HAN, X. etc. expert. Pharmaceutical Economics Pastor. result. seacoast 18(5), 505–517 (2018)